跳至主要内容
临床试验/EUCTR2017-001507-76-SE
EUCTR2017-001507-76-SE进行中(未招募)1 期

Beta-blockeRs tO patieNts with CHronIc Obstructive puLmonary diseasE (BRONCHIOLE)A pragmatic clinical trial with partial registry-based follow-up

Region Örebro län0 个研究点目标入组 1,700 人开始时间: 2017年5月8日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
进行中(未招募)
入组人数
1,700

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • A diagnosis of COPD confirmed by spirometry showing post bronchodilator value of Forced Expiratory Volume in one second (FEV1)//Forced Vital Capacity (FVC) < 70 according to the Global Initiative on Obstructive Pulmonary Disease (GOLD), and with a history of tobacco smoking or occupational/environmental exposure for smoke gas or dust
  • - =40 years of age.
  • - Sinus rhythm =50/min and <120 at inclusion.
  • - Written informed consent.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range 600
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range 1100

排除标准

  • - Known hypersensitivity to metoprolol or related derivatives.
  • - AF or other arrhythmias for which beta blockers are indicated according to
  • the investigator discretion.
  • - AV block II or III unless treated with a pacemaker.
  • - Sinus bradycardia (resting heart rate <50/min).
  • - Sick sinus syndrome unless treated with a pacemaker.
  • - Clinical signs of or a previous diagnosis of HF.
  • - Systolic blood pressure <90 mmHg.
  • - Severe bronchial asthma.
  • - Current beta-blocker treatment.
  • - Inability to provide informed consent.
  • - Age below 40 years.
  • - Acute on-going exacerbation of COPD.
  • - Previous randomization in the BRONCHIOLE trial.

研究者

相似试验